Elad Kedar

Articles by Elad Kedar

FDA approves low-dose pilocarpine hydrochloride 0.4% as a treatment for presbyopia

ByLynda Charters,Emily Kaiser Maharjan, Assistant Managing Editor,Elad Kedar,Paul Smith

October 18th 2023

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

Pipeline: Presbyopia treatment to finish Phase 3 late 2021

ByElad Kedar,Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director,Brooke Henson, Editor

June 4th 2021

Orasis Pharmaceuticals drop in development for treating presbyopia

Latest Updated Articles

Pipeline: Presbyopia treatment to finish Phase 3 late 2021
June 4th 2021

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial

Takeaways from this week in optometry: October 16-23

Brepocitinib for noninfectious uveitis meets all phase 3 trial end points

More than monitoring: Using AMD visits to promote healthy vision aging

The Independent Advantage S02 E07: Is your front desk missing opportunities?